Aurora Cannabis Sees a Path to Profitability. The Stock Trades Higher.

barrons logo

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit

  • Order Reprints

  • Print Article

Aurora Cannabis was rising Tuesday after fiscal fourth-quarter sales missed analysts’ estimates but the Canadian cannabis company said cost savings should “clear a path” for being adjusted Ebitda positive.

Analysts at MKM Partners upgraded the stock to Neutral from Sell.

Sales in the period fell to C$54.8 million from C$68.4 million a year…

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button